Burkett Financial Services’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$41.2K Hold
2,821
0.01% 113
2026
Q1
$20.9K Hold
2,821
0.01% 144
2025
Q4
$33.2K Hold
2,821
0.01% 119
2025
Q3
$21.8K Hold
2,821
0.01% 135
2025
Q2
$20.6K Hold
2,821
0.01% 125
2025
Q1
$26.8K Hold
2,821
0.01% 118
2024
Q4
$46.5K Hold
2,821
0.02% 89
2024
Q3
$41.6K Hold
2,821
0.02% 88
2024
Q2
$39.1K Hold
2,821
0.02% 86
2024
Q1
$44.3K Hold
2,821
0.02% 88
2023
Q4
$45.6K Buy
+2,821
New +$46.2K 0.03% 86

Other funds holding NEO

Burkett Financial Services's NEO Position: Q2 2026 in Review

Burkett Financial Services held its NeoGenomics (NEO) position steady in Q2 2026 at 2,821 shares worth $41.2K. The position accounts for 0.01% of the portfolio, ranked #113.

Burkett Financial Services first reported a position in NEO in Q4 2023 and has held it in 11 quarters since. The position peaked at $46.5K in Q4 2024. 35 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Burkett Financial Services held 2,821 shares of NeoGenomics worth $41.2K as of Q2 2026.
  • Burkett Financial Services left its NeoGenomics share count unchanged in Q2 2026.
  • NeoGenomics made up 0.01% of Burkett Financial Services's portfolio in Q2 2026, its #113 holding.
  • Burkett Financial Services first reported a position in NeoGenomics in Q4 2023 and has held it in 11 quarters since.
  • Burkett Financial Services's NeoGenomics position peaked at $46.5K in Q4 2024.
  • 35 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Burkett Financial Services's 13F filing for Q2 2026, filed 2 Jul 2026.